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Summary.-The SCM test was established as originally described, and an attempt
was made to evaluate it using myelin basic proteins. Various later modifications
described by the original authors were incorporated as they were communicated to
us. In separate studies attempts were also made to overcome some of the problems
which seemed inherent in the technique. In the small series for which valid results
were obtained we were unable to confirm the original claim that the method dis-
criminates between cancer patient lymphocytes and those from non-cancer subjects
with almost 9900 reliability. Indeed, although differences were found between the
mean SCM values of cancer patients and of healthy controls, these differences were
not significant.
THE "Structuredness of Cytoplasmic
Matrix" (SCM) test was reported by
Cercek et al. (1974) as a means of dis-
tinguishing between cancer patients and
normal subjects on the basis of changes in
fluorescence polarization (p) of lympho-
cytes following incubation with Cancer
Basic Protein (CaBP), Encephalitogenic
Factor (EF) and Phytohaemagglutinin
(PHA). In lymphocytes from cancer
patients a decrease in p value (compared
to the control) was observed after incuba-
tion with CaBP or EF, but not with PHA.
Conversely in lymphocytes from healthy
individuals, the p value decreased with
PHA, but not with CaBP or EF. The ratio
ofthe CaBP response to the PHA response
gave a value known as the SCM response
ratio (RRScM) by means of which a con-
fident prediction of the donor's cancer
status could be made. In this paper we
relate our experience in trying to confirm
these observations.
During the course of a Workshop held
in November 1976 and subsequently pub-
lished (Bagshawe, 1977) a revised tech-
nical protocol elucidating several crucial
points was presented. It was stated that a
graph of the fluorescein emission-polariza-
tion spectrum for "resting state" lympho-
cytes revealed a peak at 510 nm which dis-
appeared after stimulation of the cells.
This observation was fundamental to
the measurement of p-value changes in
the SCM test andinvalidated any approach
which used different light sources or mono-
chromators, a different arrangement of
polarizing filters or lenses or different
substrate conditions from those specified.
A further modification related to the
Ficoll-Triosil used for the preparation of
lymphocytes. A specific gravity at 25°C of
1-081 g/cm3 and osmolality of 320 mOsm/
kg was necessary to achieve a distinctive
two-layer separation of lymphocytes at
the plasma-gradient interface with the
SCM-responding cells present only in the
upper layer, or the upper portion if only
one layer was produced. The correct pH
(7.4) and calcium-ion concentration of the
phosphate-buffered saline (PBS) were also
critical.
In a later review (Cercek & Cercek, 1977)
these parameters were again described and
a modification whereby the substrate was
prepared to a final concentration of 6 25 x
10-7M from a stock solution in acetic acid
rather than acetone was also suggested.EVALUATION OF SCM TEST
We present results of SCM tests per-
formed in this laboratory, details of the
cells isolated, and studies on the intra-
cellular fluorescein.
MATERIALS AND METHODS
Initially the SCM tests were performed on
a Perkin-Elmer model MPF-3 spectrofluori-
meter, but the majority ofthe work was on a
model MPF-4, following the protocol as
originally described (Cercek et al., 1974) after
adoption of the various modifications des-
cribed at the 1976 Workshop. We have also
tried, as far as possible, to keep abreast ofthe
alterations in technique as they were com-
municated to us.
Reagent-grade PHA was obtained from
Wellcome Reagents Ltd. Myelin basic protein
(MBP) was prepared using an established
technique (Deibler et al., 1972).
Thymus-dependent "T" cells and bursa-
equivalent "B" cells were assessed by a
modification of a published rosetting tech-
nique (Biozzi et al., 1968).
Verification of the fluorescein emission-
polarization spectrum was attempted in a
number of ways. Firstly, by measuring p
values on the MPF-4 with the emission slit
width set at 5 nm, the emission wavelength
was varied in 5nm steps from 500 nm up to
550 nm. Secondly, p values were measured on
lymphocytes which had been incubated with
substrate and then spun to produce a pellet of
cells in a strain-free glass capillary, which
was then analysed spectrally. Finally, cells
under a Leitz microscope were illuminated
with incident Xenon light via a light guide,
and the individual cell fluorescence conducted
via another light guide to be analysed on the
MPF-4.
The kinetics of substrate uptake and
intracellular fluorescein production were de-
termined on 5x 107 lymphocytes uniformly
suspended in 100 ml of stirred substrate at
27°C. The chart recorder was started when
the cells were added and, at about 30-s
intervals, a 3-ml aliquot was removed, placed
in a cuvette, and the total fluorescence record-
ed. The sample was then filtered through a
Millipore multifiltration (24 place) manifold
and the filtration time noted. The filtrates
were measured at the end of the experiment
and the values recorded on the chart. The
cellular fluorescein was derived by the con-
ventional subtraction of the filtrate value
from the total fluorescence, and also directly
by lysis of the cells retained on the Millipore
membrane. Treatment of the lysate with
strong alkali further provided a measure of
the unhydrolysed intracellular substrate.
A simple device was constructed consisting
ofa Zinc lamp parallel light source and 2 side-
window photomultiplier tubes mounted on
either side of the thermostatically controlled
cuvette. The fluorescein emission was simul-
taneously analysed with film polarizers and
barrier filters to produce 2 signals correspond-
ing to the emission intensities parallel and
perpendicular to the exciting light source.
These were both displayed on a twin-pen
chart recorder and processed electronically to
produce a continuous read-out of p. The
apparatus was demonstrated at the Work-
shop in 1976.
RESULTS
The p values of unstimulated lympho-
cytes and after incubation with either
PHA or MPB are shown in Table I for the
original technique and for the post-
Workshop protocol. As can be seen, the
TABLE I.-Changes in mean values of p obtained in our laboratory before and after
modifications of technique introduced following the 1976 Workshop
Normal
_ K~~~
Cancer
A
Pre-Workshop
Control
PHA
MBP
Mean p
0-136
0-137
0-137
Post-Workshop
Control 0-158
PHA 0-136
MBP 0-150
°h c ofV A% p Mean p
4-3
14-3
8-0
11-9
9-4
9-3
0
0
- 13-7
-4-6
0-145
0-125
0-134
0-157
0-148
0-140
%CofV A %p
11-7
18-5
10-0
12-3
9-1
15-1
- 14-1
- 7-6
-6-2
-11-0
Average
0-141
0-131
0-136
0-158
0-142
0-145
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FIG. 1. % changes of p (fluorescence polarization) in lymphocytes from non-cancer and cancer
subjects following incubation with phytohaemagglutinin (PHA) and myelin basic protein (MBP).
Bars show mean and s.d.
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FIG. 2.-SCM response ratios (RRscM) of non-cancer and cancer subjects. Individual values plus
mean and s.d.
mean p of unstimulated lymphocytes in-
creased by 1201% from 04141 to 0-158.
This increase in p may correspond to the
use of the higher osmolality PBS (330
mOsm) introduced after the Workshop,
compared to the original Dulbecco com-
plete PBS (280 mOsm). These values are
lower than the mean value of 0 206 + 0 002
(s.e.) reported by Cercek et al. (1974) or
0 196 + 0 004 reported by Cercek & Cercek
(1977) for healthy control lymphocytes.
It does, however, fall within 1 s.d. of the
latter value (range 0-130 to 0 262) and is
comparable to the values reported by
M. Stack-Dunne (0a153 + 0-002 and 0 142
+ 0.003) and J. P. Dickinson (0-160 +
0.020) at the November 1976 Workshop.
Dickinson also found a 13% increase in
mean p for unstimulated lymphocytes
after incorporation of the Workshop
recommendations, as well as significant
improvement in the response of healthy
control lymphocytes to PHA (personal
communication).
Whereas there was little response to
either PHA or MBP shown by healthy
control lymphocytes using the original
technique, a decrease of 13.7% with PHA
and 4.6% with MBP was observed using
the revised protocol. For lymphocytes
from cancer subjects, the response to PHA
incubation changed from a decrease of
14-1% to a decrease of 6.2%, whereas the
response to MBP improved from a de-
crease of 7.6% to a decrease of 11.0%.
Although these results taken together gave
an RRSCM of 1-06 for healthy individuals
and 0 99 for cancer patients, the spread of
results for individual samples is con-
siderable, as shown in Fig. 1 (00 changes in
p) and Fig. 2 (RRscM). Only 60% ofeither
healthy controls or cancer subjects could
be considered to give the "correct"
RRSCM response, frequently because a
change in p was noted in both PHA- and
MBP-incubated lymphocytes.
An assessment of the cells found in the
2 layers was made using blood from 15
normals and 15 cancer subjects.
Simple microscopic examination, cell
count and differential count performed on
samples from both healthy individuals and
cancer patients revealed that the lower
layers were frequently contaminated by
A t
+40%
Non Cancer + PHA
A
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clumped erythrocytes, as well as poly-
morphonuclear cells (PMN) which pre-
sumably failed to ingest iron particles at
the first stage ofpreparation. Lymphocyte
purity in each layer is summarized in
Table II. The differences between the 2
layers are significant. Each layer was also
TABLE II. Purity of lymtaphocyte su8spen-
sions (°0 lIymphocytes) in each layer
Normal subjects (15) Cancer patients (15)
Upper Lower Upper Lower
layer layer layer layer
Range Range Range Range
92-99 75-95 92-99 78-92
Mean AMean Mean MAean
95-3 85s3 95 2 83-7
P<00(5 P<0 01
TrABLE III. E-rosettable lymphocytes (%)
in each layer
Normal subjects (15)
-
-
Upper Lower
layer layer
Range Range
30-153-3 20 1-48 8
Mean Alean
44 2 408
P<0.01
Cancer patients (15)
Upper Lower
layer layer
Range Range
36;2-51-7 325 5-503
AMean Mean
43-9 40 5
P <0.05
TABLE IV. EAC-rosettable lymphocytes
(Oo) in each layer
Normal subjects (15) Cancer patients (15)
Uppei Lower Upper Lower
layer layer layer layei
Range Range Range Range
7 4-16-2 7 -2-21 1 6 6-1905 9,6-21 6
Mean Mean Alean Alean
10 8 13:9 119. 16-3
1' <0)05 P<00l
assessed in terms of T and B cells by the
rosetting technique. The results in Tables
III and IV show that the ratio of T cells
(E rosetting) to B cells (EAC rosetting) is
significantly greater in the upper-layer
lymphocytes.
The fluorescein emission-polarization
spectrum for a number of different
lymphocytes revealed a broad plateau
around 525 nm, without the described
53
sharp peak at 510 nm. In addition, the
studies on the packed cells showed a pro-
nounced "Red Shift" (Ama= 527 nm),
indicating an intracellular fluorescein con-
centration ofgreater than 10-5M. This was
confirmed microscopically, despite rapid
photobleaching.
The results of the multifiltration experi-
ments are displayed in Fig. 3 and show
that the intracellular fluorescein concen-
tration levels out after about 10 min and
that the polarization decreases with the
increasing cellular level, which is in agree-
ment with findings already published
(Preece et al., 1978).
Direct measurement of cell lysates in-
dicated that the intracellular FDA reached
a maximum within 30 s and that the
cellular fluorescein was considerably in
excess of the value calculated by subtrac-
tion of filtrate from total fluorescein. This
suggests that significant quenching of
fluorescein is occurring within the cell.
Results obtained on the direct polariza-
tion instrument showed p to remain con-
stant for several minutes at the start of
the reaction, and then to reduce as the
fluorescein released from the cells accumu-
lated in the background. The lymphocyte
p values obtained by this direct method
were somewhat lower than those obtained
on the MPF-4, averaging 0d130.
0.200
TIME (CIINUTES)
FIG. 3.-Broken line-clhange of p with timo.
Soli(t lines increase in fluorescein con-
centrations Nith time. Total concentration
refers to the total fluorescence output (III +
2J1) from the cellandl substrate suspension.
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DISCUSSION
The phenomenon of fluorescence is
initiated by the interaction of a photon of
exciting light with the electron cloud of a
suitably oriented fluorescent probe mole-
cule. There is then a rearrangement of the
quantum of energy within the molecule
which takes a length of time known as
tau (X) during which the molecule may
rotate. Finally, a photon is ejected at a
longer wavelength, since there is an energy
loss during the process, and this photon is
polarized in the same plane relative to the
molecule as the original photon which was
absorbed. It follows that analysis of the
plane of the polarization of the light
emitted following excitation with polar-
ized light indicates by how much the
molecules have rotated during the time, r.
In highly viscous media, the molecules can
rotate little and the emitted light will
nearly all be parallel to the exciting light.
In very low-viscosity media, the molecules
will have rotated to a state of randomness
before emission, therefore analysis will
show the photons to be equally distri-
buted, parallel and perpendicular to the
exciting lighit.
Fluorescence-polarization measurement
is a very useful tool for the study of the
environment in which the probe is located
and a wide variety of different compounds
have been used to study different regions
of the cell.
In our study, although the population
was far from ideal in terms of non-
malignant controls, age-matching or num-
bers, significant discrimination between
healthy controls and cancer subjects
should have been expected on the basis of
the published techniques.
Whilst there was some improvement in
response to PHA or MBP using the revised
protocol, the "correct" diagnosis of
only 60% of all cases is unsatisfactory.
An area of particular concern is the very
wide distribution of responses in both
groups.
The improvement in response to stimu-
lation may have resulted from the use of
Ficoll-Triosil at a higher density, since
PMNs (presumably effete) and clumped
erythrocytes were found to a significant
extent in the lower layer and could have
contaminated the earlier lower-density
preparations.
Our failure to confirm the existence of
the spectrum described by Dr Cercek
raises several points for speculation. Fig. 3
indicates the rate of build-up of intra-
cellular fluorescein, reaching 3 x 10-9M
during a typical SCM test. The actual
lymphocyte cell volume, however, is of
the order of 0.1 p per 3 ml of substrate,
so the cellular concentration would be
approximately 10-5M, which accounts for
the observed red shift in the emission
spectrum. It also supports the observation
(Udkoff & Norman, 1979; Balding et al.,
1980; Hashimoto et al., 1979) that there is
a dependence of polarization oIn intra-
cellular fluorescein concentration, which
we confirm (Fig. 3) by the decreasing
value of p with increasing time. We also
confirm that whilst the fluorescein absorp-
tion peak (491 nm) is unaffected by con-
centrations up to 10-2M, a significant red
shift (up to 505 nm) is produced when the
dye is bound by protein. All these effects
help to compound the difficulties in
accurately quantifying the probe, and
perhaps suggest that the measurement of
the SCM phenomenon depends on the
involvement of a series of artefacts, the
balance of which may be altered by the
state of health of the donor.
The purpose-built device for directly
measuring p was criticized on the basis of
the existence of the emission polarization
peak at 510 nm, which specifically dis-
appears when the cell is stimulated, and
forms the basis of the SCM test (Cercek
et al., 1978). This suggested that only very
narrow bandwidth filters or gratings
could be used to observe the change.
Indeed, the sole invalidating argument
against this approach rests on the exist-
ence of an emission-polarization spectrum
which remains unconfirmed.
The reasoning behind the design and
construction of this inexpensive instru-
ment was as follows: most of the energyEVALUATION OF SCM TEST 777
from the Zinc lamp is concentrated into
3 emission lines at 468, 471 and 480 nm,
which lie within the absorption spectrum
of fluorescein. The use of parallel light
from this source overcomes the objection
to the extremely low source radiance. The
advantage of having simultaneous parallel
and perpendicular analyses of fluorescence
is in the avoidance oftheneedto change the
axis of the analyser at frequent intervals,
which is necessary on single-photomulti-
plier devices, and it also means that the
signals can be processed electronically to
monitor polarization continuously. Kinetic
studies suggested that a valid measure of
cellular polarization could be obtained
during the initial stages of the reaction,
whilst the background fluorescence is
minimal. If so, this would avoid the need
for mechanical filtration of the cells
which was considered by us to be the
weakest and yet most important step in
the SCM test as described by the Cerceks.
Chromium-labelling experiments by us
suggested that lysis of cells during Milli-
pore filtration could be as much as 20%,
and this would raise the value of p by
lowering the cellular contribution to the
apparent total.
In conclusion, therefore, we have been
unable to achieve satisfactory distinction
between lymphocyte samples from healthy
donors or cancer patients using the SCM
test, either as originally described or as
subsequently modified.
This work was supported by a grant from the
Cancer Researchl Campaign and the MIedfical Research
Couneil.
REFERENCES
BAGSHAW\E, K. D. (1977) Workshlop on macroplhage
electrophoretic mobility (AIEM) aind structured-
ness of cytoplasmic matrix (SCAI) tests. Br. J.
Cancer, 35, 701.
BALDING, P., LIGHT, P. A. & PREECE, A. W. (1980)
Response of human lymphocytes to PHA and
tumour-associated antigens as detected by fluores-
cence polarization, Br. J. Cancer, 41, 73.
Biozzi, G., STIFFEL, C., MOUTON, D., BOUTHILLIER,
Y. & DECREUSEFOND, C. (1968) A kinetic study of
antibody producing cells in the spleen of mice
immunize(c intravenously with sheep erythro-
cytes. Immunology, 14, 7.
CERCEK, L. & CERCEK, B. (1977) Application of the
phenomenon of changes in the structuredness of
cytoplasmic matrix (SCM) in the diagnosis of
malignant disorders: A review. Eur. J. Cancer,
13, 903.
CERCEK, L., CERCEK, B. & FRANKLIN, C. I. V. (1974)
Biophysical differentiation between lymphocytes
from healthy donors, patients with malignant
diseases and other disorders. Br. J. Cancer, 29, 345.
CERCEK, L., CERCEK, B. & OCKEY, C. H. (1978)
Fluorescein excitation and emission polarization
spectra in living cells. Biophys. J., 23, 395.
DEIBLER, G. E., AIARTENSON, R. E. & KIES, M. W.
(1972) Large scale preparation of myelin basic
protein from central nervous tissue of several
mammalian species. Prep. Biochem., 2, 139.
HASHIMOTO, Y., TAKAKU, F. & YAMANAKA, T. (1979)
Changes in structuredness of cytoplasmic matrix
in single stimulated lymphocytes from healthy
donors and patients with non-malignant and
malignant diseases. Br. J. Cancer, 40, 156.
PREECE, A. W., LIGHT, P. A. & BALDING, P. (1978)
Fluorochromasia and fluorescence polarization in
lymphoid cells. Br. J. Cancer, 38, 197.
UDKOFF, R. & NORAIAN, A. (1979) Polarization of
fluorescein fluorescence in single cells. J. Hi8to-
chem. Cytochem., 27, 49.